In the metastatic model of NSCLC, CCR2b.B7-H3.28 CAR-T cells showed slightly enhanced antitumor activity compared to B7-H3.28 CAR-T cells (Supplementary Fig. 6a–f). Here, CCR2 is linked to non-small cell lung carcinoma.